We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Edaravone Attenuates Aβ 1-42-Induced Inflammatory Damage and Ferroptosis in HT22 Cells.
- Authors
Guo, Shenglong; Lei, Qi; Guo, Hena; Yang, Qian; Xue, Yanli; Chen, Ruili
- Abstract
Ferroptosis and neuroinflammation play a crucial role in the pathogenesis of Alzheimer's disease (AD), and Edaravone (EDA) has been demonstrated to have anti-inflammatory, antioxidant and neuroprotective effects in neurodegenerative diseases. However, the relationship between EDA and ferroptosis in AD is unidentified. This research aimed to elucidate the mechanism of EDA in AD with Aβ 1-42-induced HT22 cells as in vitro cell model. The results showed that EDA could significantly reduce Aβ1-42-induced apoptosis of HT22 cells and formation of pro-inflammatory factors TNF-α, IL-1β and IL-6, prevent the activation of TLR4/NF-κB /NLRP3 signaling pathway, and inhibit ferroptosis and lipid peroxidation. Taken together, EDA contributes to inhibiting neuroinflammatory injury and ferroptosis in Aβ 1-42-induced HT22 cells, and thus may be a potential candidate for the treatment of AD.
- Subjects
EDARAVONE; ALZHEIMER'S disease; NEURODEGENERATION
- Publication
Neurochemical Research, 2023, Vol 48, Issue 2, p570
- ISSN
0364-3190
- Publication type
Article
- DOI
10.1007/s11064-022-03782-y